← Back to Clinical Trials
Recruiting Phase 2 NCT05235919

Treatment to Promote Self-regulation in Children With Autism Spectrum Disorder

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Autism Spectrum Disorder
Sponsor Holland Bloorview Kids Rehabilitation Hospital
Study Type INTERVENTIONAL
Phase Phase 2
Enrollment 50
Sex ALL
Min Age 9 Years
Max Age 18 Years
Start Date 2022-09-22
Completion 2025-02
Interventions
repetitive transcranial magnetic stimulation (rTMS)Sham stimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study will evaluate the feasibility of repetitive Transcranial Magnetic Stimulation (rTMS) in Autism Spectrum Disorder (ASD) with self-regulation impairment. Baseline and follow-up participant visits will include behavioral assessments of self-regulation and magnetic resonance imaging (MRI) to determine neurophysiological outcomes before and after rTMS treatment.

Eligibility Criteria

Inclusion Criteria: * Children with a diagnosis of autism spectrum disorder and self-regulation impairment or challenges * Able to participate in rTMS Exclusion Criteria: * Children with autism spectrum disorder but no co-morbid self-regulation disorders. * Children with contraindications to TMS (history of seizures, family history of seizures, metal implants) * Co-existing neurological conditions (epilepsy, stroke, etc.)

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE AUTISM SPECTRUM DISORDER TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}